Two new NNRTIs enter the pipeline.
Dalton
Paul
P
D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use*; D010721:Phosphinic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*
C534138:IDX 899; D007211:Indoles; D010721:Phosphinic Acids; D010919:Placebos; D018894:Reverse Transcriptase Inhibitors